PortfoliosLab logoPortfoliosLab logo
MRK vs. ELVA
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

MRK vs. ELVA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Merck & Co., Inc. (MRK) and Electrovaya Inc. Common Shares (ELVA). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, MRK achieves a 13.94% return, which is significantly lower than ELVA's 20.25% return. Over the past 10 years, MRK has outperformed ELVA with an annualized return of 11.59%, while ELVA has yielded a comparatively lower 2.89% annualized return.


MRK

1D
-1.42%
1M
6.89%
YTD
13.94%
6M
20.60%
1Y
50.99%
3Y*
5.87%
5Y*
12.81%
10Y*
11.59%

ELVA

1D
-3.16%
1M
-0.52%
YTD
20.25%
6M
43.50%
1Y
181.07%
3Y*
37.56%
5Y*
9.63%
10Y*
2.89%
*Multi-year figures are annualized to reflect compound growth (CAGR)

MRK vs. ELVA - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
MRK
Merck & Co., Inc.
13.94%9.79%-6.26%1.01%49.42%1.75%-7.20%22.27%39.95%-1.49%
ELVA
Electrovaya Inc. Common Shares
20.25%218.55%-18.95%-17.30%2.78%-38.98%686.67%48.08%-80.52%-67.02%

Correlation

The correlation between MRK and ELVA is 0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.06

Correlation (3Y)
Calculated over the trailing 3-year period

0.07

Correlation (5Y)
Calculated over the trailing 5-year period

0.03

Correlation (10Y)
Calculated over the trailing 10-year period

0.03

Correlation (All Time)
Calculated using the full available price history since Jan 8, 2016

0.03

Fundamentals

Market Cap

MRK:

$294.29B

ELVA:

$490.77M

EPS

MRK:

$3.58

ELVA:

$0.11

PE Ratio

MRK:

33.21

ELVA:

87.86

PEG Ratio

MRK:

0.03

ELVA:

1.04

PS Ratio

MRK:

4.52

ELVA:

6.21

PB Ratio

MRK:

6.41

ELVA:

7.79

Total Revenue (TTM)

MRK:

$65.59B

ELVA:

$70.74M

Gross Profit (TTM)

MRK:

$49.79B

ELVA:

$22.01M

EBITDA (TTM)

MRK:

$22.69B

ELVA:

$6.86M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

MRK vs. ELVA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MRK
MRK Risk / Return Rank: 8888
Overall Rank
MRK Sharpe Ratio Rank: 8888
Sharpe Ratio Rank
MRK Sortino Ratio Rank: 8888
Sortino Ratio Rank
MRK Omega Ratio Rank: 8585
Omega Ratio Rank
MRK Calmar Ratio Rank: 9191
Calmar Ratio Rank
MRK Martin Ratio Rank: 9090
Martin Ratio Rank

ELVA
ELVA Risk / Return Rank: 8787
Overall Rank
ELVA Sharpe Ratio Rank: 8989
Sharpe Ratio Rank
ELVA Sortino Ratio Rank: 8686
Sortino Ratio Rank
ELVA Omega Ratio Rank: 8484
Omega Ratio Rank
ELVA Calmar Ratio Rank: 8888
Calmar Ratio Rank
ELVA Martin Ratio Rank: 8787
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MRK vs. ELVA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Merck & Co., Inc. (MRK) and Electrovaya Inc. Common Shares (ELVA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


MRKELVADifference
Sharpe ratioReturn per unit of total volatility

-0.12

Sortino ratioReturn per unit of downside risk

+0.16

Omega ratioGain probability vs. loss probability

1.33

1.32

+0.01

Calmar ratioReturn relative to maximum drawdown

4.49

3.80

+0.69

Martin ratioReturn relative to average drawdown

11.22

9.01

+2.20

MRK vs. ELVA - Sharpe Ratio Comparison

The current MRK Sharpe Ratio is 1.88, which is comparable to the ELVA Sharpe Ratio of 2.00. The chart below compares the historical Sharpe Ratios of MRK and ELVA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

MRK vs. ELVA - Drawdown Comparison

The maximum MRK drawdown since its inception was -68.61%, smaller than the maximum ELVA drawdown of -96.90%. Use the drawdown chart below to compare losses from any high point for MRK and ELVA.


Loading charts...

Drawdown Indicators


MRKELVADifference

Max Drawdown

Largest peak-to-trough decline

-68.61%

-96.90%

+28.29%

Max Drawdown (1Y)

Largest decline over 1 year

-11.37%

-44.42%

+33.05%

Max Drawdown (3Y)

Largest decline over 3 years

-43.44%

-64.19%

+20.75%

Max Drawdown (5Y)

Largest decline over 5 years

-43.44%

-66.78%

+23.34%

Max Drawdown (10Y)

Largest decline over 10 years

-43.44%

-96.90%

+53.46%

Current Drawdown

Current decline from peak

-5.03%

-41.01%

+35.98%

Average Drawdown

Average peak-to-trough decline

-18.83%

-73.62%

+54.79%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.54%

18.71%

-14.17%

Volatility

MRK vs. ELVA - Volatility Comparison

The current volatility for Merck & Co., Inc. (MRK) is 9.57%, while Electrovaya Inc. Common Shares (ELVA) has a volatility of 27.27%. This indicates that MRK experiences smaller price fluctuations and is considered to be less risky than ELVA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


MRKELVADifference

Volatility (1M)

Calculated over the trailing 1-month period

9.57%

27.27%

-17.70%

Volatility (6M)

Calculated over the trailing 6-month period

18.04%

63.77%

-45.73%

Volatility (1Y)

Calculated over the trailing 1-year period

27.18%

84.18%

-57.00%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

23.66%

69.12%

-45.46%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

22.96%

86.10%

-63.14%

Dividends

MRK vs. ELVA - Dividend Comparison

MRK's dividend yield for the trailing twelve months is around 2.79%, while ELVA has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
ELVA
Electrovaya Inc. Common Shares
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
MRK
Merck & Co., Inc.
2.79%3.12%3.14%2.72%2.52%3.41%3.03%2.48%2.60%3.36%3.14%3.43%

Financials

MRK vs. ELVA - Financials Comparison

This section allows you to compare key financial metrics between Merck & Co., Inc. and Electrovaya Inc. Common Shares. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20222023202420252026
16.29B
17.80M
(MRK) Total Revenue
(ELVA) Total Revenue
Values in USD except per share items

MRK vs. ELVA - Profitability Comparison

The chart below illustrates the profitability comparison between Merck & Co., Inc. and Electrovaya Inc. Common Shares over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%20222023202420252026
81.9%
31.0%
Portfolio components
MRK - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Merck & Co., Inc. reported a gross profit of 13.34B and revenue of 16.29B. Therefore, the gross margin over that period was 81.9%.

ELVA - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Electrovaya Inc. Common Shares reported a gross profit of 5.51M and revenue of 17.80M. Therefore, the gross margin over that period was 31.0%.

MRK - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Merck & Co., Inc. reported an operating income of -1.88B and revenue of 16.29B, resulting in an operating margin of -11.6%.

ELVA - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Electrovaya Inc. Common Shares reported an operating income of 1.52M and revenue of 17.80M, resulting in an operating margin of 8.5%.

MRK - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Merck & Co., Inc. reported a net income of -4.24B and revenue of 16.29B, resulting in a net margin of -26.0%.

ELVA - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Electrovaya Inc. Common Shares reported a net income of 1.00M and revenue of 17.80M, resulting in a net margin of 5.6%.


Frequently Asked Questions


MRK and ELVA have a correlation of 0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ELVA has higher volatility (27.27%) compared to MRK (9.57%). In terms of maximum drawdown, MRK dropped -68.61% vs ELVA's -96.90%.

ELVA currently has the higher Sharpe Ratio (2.00 vs 1.88), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for MRK and ELVA

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer